Jilin Province Great Great Pharmaceutical Co. LTD

Jilin Province Broadwell Pharmaceutical Co., LTD. Welcome you!

Service hotline:+86-431-85639055

博大伟业
imgboxbg

NEWS CENTER

Your current location:
Homepage
/
/
The first non-public enterprise science and technology Association in Liaoyuan city was established in the company

The first non-public enterprise science and technology Association in Liaoyuan city was established in the company

  • Categories:News center
  • Author:2020-9-18 13:20
  • Origin:
  • Time of issue:2020-10-09
  • Views:0

(Summary description)On August 30, 2017, the first non-public enterprise science and Technology Association of Liaoyuan was established in the company. Ma Xiujun, President of the Municipal Association of Science and Technology, Li Xiuwu, vice minister of the Municipal United Front Work Department and secretary of the Municipal Federation of Industry and Commerce attended the inaugural meeting and made an important speech.



Science and Technology Association of Jilin Broad Great Pharmaceutical Co., Ltd. is a mass organization voluntarily constituted by the scientific and technological workers of the company, a bridge and link between the party organization and the management and decision-making level of the company and the scientific and technological workers, and an important force to promote the scientific and technological progress and technological innovation of the company.



Jilin province broad weiye pharmaceutical co., LTD. Since its inception, has always been to respect life, safeguard human health as the mission, to adopt the essence of science and technology, create achievements in one hundred as the core values, in biology, medicine is based on two research and development platform, is the President unit of the medicine industry of jilin province technology innovation strategic alliance, the jilin province medicine pilot center. The company focuses on biochemical, biopharmaceutical, and gathers in the research and development, production and sales of cardiovascular and cerebrovascular, digestive, anti-cancer, neuropsychiatric drugs.



The company has a production line with the new VERSION of GMP and with imported and domestic advanced equipment, which produces 3,500 tons of API, 50 million pieces of biological preparation, 20 million pieces of large infusion, 80 million pieces of small capacity injection and 3 billion pieces of solid preparation. The company independently developed a new generation of treatment of gastric ulcer of the third class of national new drug - Juprezinc-launched on the market, by clinicians and related experts widely recognized and stomach patients convinced and welcome. The product was rated as one of the top 10 prescription drugs in China at the 68th National Drug Fair in 2012. After review by jilin famous brand product promotion Committee, it was rated as Jilin famous brand product. The company and Beijing Northland Biotechnology Co., LTD. Jointly developed, the national first class biological new drug recombinant human interleukin-11, is used for cancer patients caused by chemoradiotherapy thrombocytopenia biological preparation, is the world, China's material invention patent, is the world's revolutionary innovative drugs.



At present, the company's scientific and technological achievements have been transformed and industrialized production of 15 varieties, 16 varieties have been declared to the State Administration of Medicine for approval, and 6 varieties are under research. The company has basically formed a strategic pattern of production generation, reserve generation and research generation.

The first non-public enterprise science and technology Association in Liaoyuan city was established in the company

(Summary description)On August 30, 2017, the first non-public enterprise science and Technology Association of Liaoyuan was established in the company. Ma Xiujun, President of the Municipal Association of Science and Technology, Li Xiuwu, vice minister of the Municipal United Front Work Department and secretary of the Municipal Federation of Industry and Commerce attended the inaugural meeting and made an important speech.



Science and Technology Association of Jilin Broad Great Pharmaceutical Co., Ltd. is a mass organization voluntarily constituted by the scientific and technological workers of the company, a bridge and link between the party organization and the management and decision-making level of the company and the scientific and technological workers, and an important force to promote the scientific and technological progress and technological innovation of the company.



Jilin province broad weiye pharmaceutical co., LTD. Since its inception, has always been to respect life, safeguard human health as the mission, to adopt the essence of science and technology, create achievements in one hundred as the core values, in biology, medicine is based on two research and development platform, is the President unit of the medicine industry of jilin province technology innovation strategic alliance, the jilin province medicine pilot center. The company focuses on biochemical, biopharmaceutical, and gathers in the research and development, production and sales of cardiovascular and cerebrovascular, digestive, anti-cancer, neuropsychiatric drugs.



The company has a production line with the new VERSION of GMP and with imported and domestic advanced equipment, which produces 3,500 tons of API, 50 million pieces of biological preparation, 20 million pieces of large infusion, 80 million pieces of small capacity injection and 3 billion pieces of solid preparation. The company independently developed a new generation of treatment of gastric ulcer of the third class of national new drug - Juprezinc-launched on the market, by clinicians and related experts widely recognized and stomach patients convinced and welcome. The product was rated as one of the top 10 prescription drugs in China at the 68th National Drug Fair in 2012. After review by jilin famous brand product promotion Committee, it was rated as Jilin famous brand product. The company and Beijing Northland Biotechnology Co., LTD. Jointly developed, the national first class biological new drug recombinant human interleukin-11, is used for cancer patients caused by chemoradiotherapy thrombocytopenia biological preparation, is the world, China's material invention patent, is the world's revolutionary innovative drugs.



At present, the company's scientific and technological achievements have been transformed and industrialized production of 15 varieties, 16 varieties have been declared to the State Administration of Medicine for approval, and 6 varieties are under research. The company has basically formed a strategic pattern of production generation, reserve generation and research generation.

  • Categories:News center
  • Author:2020-9-18 13:20
  • Origin:
  • Time of issue:2020-10-09
  • Views:0
Information

On August 30, 2017, the first non-public enterprise science and Technology Association of Liaoyuan was established in the company. Ma Xiujun, President of the Municipal Association of Science and Technology, Li Xiuwu, vice minister of the Municipal United Front Work Department and secretary of the Municipal Federation of Industry and Commerce attended the inaugural meeting and made an important speech.

Science and Technology Association of Jilin Broad Great Pharmaceutical Co., Ltd. is a mass organization voluntarily constituted by the scientific and technological workers of the company, a bridge and link between the party organization and the management and decision-making level of the company and the scientific and technological workers, and an important force to promote the scientific and technological progress and technological innovation of the company.

Jilin province broad weiye pharmaceutical co., LTD. Since its inception, has always been to respect life, safeguard human health as the mission, to adopt the essence of science and technology, create achievements in one hundred as the core values, in biology, medicine is based on two research and development platform, is the President unit of the medicine industry of jilin province technology innovation strategic alliance, the jilin province medicine pilot center. The company focuses on biochemical, biopharmaceutical, and gathers in the research and development, production and sales of cardiovascular and cerebrovascular, digestive, anti-cancer, neuropsychiatric drugs.

The company has a production line with the new VERSION of GMP and with imported and domestic advanced equipment, which produces 3,500 tons of API, 50 million pieces of biological preparation, 20 million pieces of large infusion, 80 million pieces of small capacity injection and 3 billion pieces of solid preparation. The company independently developed a new generation of treatment of gastric ulcer of the third class of national new drug - Juprezinc-launched on the market, by clinicians and related experts widely recognized and stomach patients convinced and welcome. The product was rated as one of the top 10 prescription drugs in China at the 68th National Drug Fair in 2012. After review by jilin famous brand product promotion Committee, it was rated as Jilin famous brand product. The company and Beijing Northland Biotechnology Co., LTD. Jointly developed, the national first class biological new drug recombinant human interleukin-11, is used for cancer patients caused by chemoradiotherapy thrombocytopenia biological preparation, is the world, China's material invention patent, is the world's revolutionary innovative drugs.

At present, the company's scientific and technological achievements have been transformed and industrialized production of 15 varieties, 16 varieties have been declared to the State Administration of Medicine for approval, and 6 varieties are under research. The company has basically formed a strategic pattern of production generation, reserve generation and research generation.

Scan the QR code to read on your phone

Jilin Province Great Great Pharmaceutical Co. LTD

Service hotline

+86-431-81158731

CONTACT US

Jilin Province Great Great Pharmaceutical Co. LTD

Jilin Province Great Great Pharmaceutical Co. LTD
Jilin Province Great Great Pharmaceutical Co. LTD
Jilin Province Great Great Pharmaceutical Co. LTD
Jilin Province Great Great Pharmaceutical Co. LTD
Jilin Province Great Great Pharmaceutical Co. LTD
Jilin Province Great Great Pharmaceutical Co. LTD

Liaoyuan Production Base: No. 158 Fortune Road, Liaoyuan Economic Development Zone, Jilin Province

Tel:+86-437-6998023

Changchun R&D Center: No. 3786 Juye Street, Jingyue Development Zone, Changchun City, Jilin Province
Tel:+86-431-81158731(Marketing center)

Tel:+86-431-81158756(Research and development center)

Beijing Office: Room 901, Building F, Kaixuan City, 170 Beiyuan Road, Chaoyang District, Beijing
Tel:+86-10-58236233

Medication consultation, feedback on medication adverse reaction, and user complaint telephone:0437-5029815 

NO PUBLIC

Jilin Province Great Great Pharmaceutical Co. LTD

Scan and follow the official official account

Copyright © Jilin Province Great Great Pharmaceutical Co. LTD        吉ICP备20002630号

Website construction:300.cn Changchun   management     

Jilin Province Great Great Pharmaceutical Co. LTD